Cambridge Investment Research Advisors
ALSN icon

Cambridge Investment Research Advisors’s Allison Transmission ALSN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ALSN Stock Details ALSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$890K Sell
7,892
-468
-6% -$56.8K ﹤0.01% 2420
2026
Q1 		$979K Buy
8,360
+1,153
+16% +$131K ﹤0.01% 2190
2025
Q4 		$706K Sell
7,207
-1,040
-13% -$91.2K ﹤0.01% 2412
2025
Q3 		$700K Buy
8,247
+138
+2% +$12.3K ﹤0.01% 2351
2025
Q2 		$770K Buy
8,109
+171
+2% +$16.5K ﹤0.01% 2152
2025
Q1 		$759K Sell
7,938
-1,502
-16% -$159K ﹤0.01% 2078
2024
Q4 		$1.02M Sell
9,440
-2,944
-24% -$321K ﹤0.01% 1859
2024
Q3 		$1.19M Buy
12,384
+2,030
+20% +$174K ﹤0.01% 1735
2024
Q2 		$786K Buy
10,354
+837
+9% +$64.1K ﹤0.01% 1939
2024
Q1 		$772K Sell
9,517
-1,684
-15% -$114K ﹤0.01% 1911
2023
Q4 		$651K Buy
11,201
+586
+6% +$32.7K ﹤0.01% 1974
2023
Q3 		$627K Buy
10,615
+1,781
+20% +$105K ﹤0.01% 1909
2023
Q2 		$499K Buy
8,834
+675
+8% +$33.2K ﹤0.01% 2137
2023
Q1 		$369K Buy
8,159
+464
+6% +$20.8K ﹤0.01% 2303
2022
Q4 		$320K Sell
7,695
-2,215
-22% -$91K ﹤0.01% 2378
2022
Q3 		$335K Sell
9,910
-243
-2% -$9.09K ﹤0.01% 2273
2022
Q2 		$390K Buy
+10,153
New +$388K ﹤0.01% 2150
2019
Q4 		– Sell
-4,361
Closed -$205K – 2407
2019
Q3 		$205K Sell
4,361
-2,830
-39% -$128K ﹤0.01% 2099
2019
Q2 		$333K Sell
7,191
-2,645
-27% -$120K ﹤0.01% 1682
2019
Q1 		$442K Sell
9,836
-1,071
-10% -$50.8K ﹤0.01% 1573
2018
Q4 		$479K Buy
10,907
+112
+1% +$5.19K 0.01% 1347
2018
Q3 		$561K Buy
10,795
+1,168
+12% +$54.8K 0.01% 1372
2018
Q2 		$390K Buy
9,627
+4,381
+84% +$180K ﹤0.01% 1553
2018
Q1 		$205K Sell
5,246
-266
-5% -$11K ﹤0.01% 1948
2017
Q4 		$237K Buy
5,512
+114
+2% +$4.64K ﹤0.01% 1807
2017
Q3 		$203K Buy
+5,398
New +$197K ﹤0.01% 1818

Other funds holding ALSN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cambridge Investment Research Advisors's ALSN Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Allison Transmission (ALSN) stake by 5.6% in Q2 2026, selling an estimated $56.8K and leaving 7,892 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #2420.

Cambridge Investment Research Advisors first reported a position in ALSN in Q3 2017 and has held it in 26 quarters since. The position peaked at $1.19M in Q3 2024. 569 funds tracked by Wall St. Rank hold ALSN as of Q2 2026.

  • Cambridge Investment Research Advisors held 7,892 shares of Allison Transmission worth $890K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 468 Allison Transmission shares in Q2 2026, an estimated $56.8K.
  • Allison Transmission made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2420 holding.
  • Cambridge Investment Research Advisors first reported a position in Allison Transmission in Q3 2017 and has held it in 26 quarters since.
  • Cambridge Investment Research Advisors's Allison Transmission position peaked at $1.19M in Q3 2024.
  • 569 funds tracked by Wall St. Rank held Allison Transmission as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.